Prostate Cancer Research
PCF empowers the world’s top scientific minds by cutting red tape and encouraging collaboration to speed breakthroughs. Learn more about our unique funding strategies and important discoveries.
New Developments in Prostate Cancer Research
- 7/17/2015Study Questions Radiation Use for 'Low-Risk' Prostate Cancers
- 7/7/2015'Watchful Waiting' Becoming More Common for Prostate Cancer Patients
- 6/24/2015A New Genomic Classifier Enables Diagnosis of the Aggressive Neuroendocrine Subclass of Treatment-Resistant Prostate Cancer
- 6/09/2015Earlier Chemotherapy May Extend Patient Survival in Multiple Prostate Cancer Settings
- 6/02/2015The Discovery of New Molecular Mechanisms that May Link Obesity and High Risk Prostate Cancer
- 5/29/2015 Excess Weight Linked to Worse Prostate Cancer Prognosis
- 5/26/2015The PARP-Inhibitor Olaparib May Be the First Precision Medicine Therapy to Reach Prostate Cancer Patients
- 5/21/2015The Prostate Cancer Foundation-International Prostate Cancer Dream Team demonstrates the value of cancer precision medicine strategies
- 5/17/2015Prostate Cancer Testing Drops Off Following Controversial Guidelines
Respond to an open PCF Request for Applications.
The DoD and PCF-funded Prostate Cancer Clinical Trials Consortium fosters collaboration across leading cancer centers and scientists.
Annual meeting of prostate cancer researchers.
Summaries of PCF's meetings with leading cancer researchers.